期刊文献+

卡维地洛治疗慢性心力衰竭42例疗效观察 被引量:3

下载PDF
导出
摘要 目的观察卡维地洛治疗慢性心力衰竭(CHF)的临床疗效。方法80例CHF患者随机分为观察组(42例)和对照组(38例),两组均给予常规抗心衰治疗,包括休息、限盐、使用洋地黄、利尿剂、血管紧张素转换酶抑制剂和硝酸酯类药物治疗,观察组在常规治疗的基础上加用卡维地洛治疗。观察患者治疗前后的心功能分级,超声心动图测量左室舒张末期内径(LVDD)、左室收缩末期内径(LVDS)及左室射血分数(LVEF)。结果经过3个月的治疗,与对照组比较,观察组心功能及LVEF明显改善,LVDD和LVDS显著缩小,差异有统计学意义。结论在常规治疗的基础上加用卡维地洛治疗CHF,能阻断心肌重塑,改善心功能。
作者 杨勇
出处 《内科》 2007年第5期766-767,共2页 Internal Medicine
  • 相关文献

参考文献4

二级参考文献34

  • 1张凤如,陈晓文,王伟,龚兰生.卡维地洛治疗慢性心力衰竭的临床疗效及安全性观察[J].中华心血管病杂志,2004,32(9):821-822. 被引量:19
  • 2[11]Santos DJ, Moreno AJ. Inhibition of heart mitochondrial lipid peroxidation by non-toxic concentrations of carvedilol and its analog BM-910228 [J]. Biochem Pharmacol ,2001,61 (2): 155-164.
  • 3[12]Noguchi N, Nishino K,Niki E. Antioxidant action of the antihypertensive drug,carvedilol, against lipid peroxidation [J]. Biochem Pharmacol, 2000, 59 ( 9 ):1069-1076.
  • 4[13]Rossig L, Haendeler J, Mallat Z, et al. Congestive heart failure induces endothelial cell apoptosis :protective role of carvedilol [J]. J Am Coll Cardilo,2001 ,36( 7 ) :2081-2089.
  • 5[14]Romeo F,LiM D,Shi M ,et al. Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells:modulation of Fas/Fsa ligand and caspase-3 pathway [ J ]. Cardiovasc Res, 2000,45 ( 3 ) :788-794.
  • 6[15]Cao F,Chen J,Lopez BL,et al. Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model [ J ]. Eur J Pharmacol,2000,406( 1 ) :109-116.
  • 7[16]Wei S.Chow LT,Sanderson JE,et al. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction[J]. J Am Coll Cardiol.2000,36( 1 ) :276-281.
  • 8[17]Ohta Y, Watanabe K, Nakazawa M,et al. Carvedilol enhances atrial and brain natriuretic peptide mRNA expression and release in rat heart[ J ]. J Cardiovasc Pharmacol,2000,36 ( suppl 2 ) 19-23.
  • 9[18]Savitz SI, Erhardt JA, Anhtony JV, et al. The novel β-bolcker, carvedilol, provides neuroprotection in transient focal stroke[J]. J Cereb Blood Flow Metab,2000,20(8) :1197-1204.
  • 10[19]Karle CA, Kreye VA,Thomas D, et al. Antarrhythmic drug carvedilol inhibits HERG potassium channels [ J ]. Cardiovasc Res,2001,49 ( 2 ): 361-370.

共引文献2473

同被引文献33

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部